The Coalition for Patient Rights Advocacy for Access to Medicines is pursuing a judicial review of the 2024 Indonesian Patent Law, calling for the return of crucial protections against patent evergreening.

Access to medicines activists warn the new US–UK pharma deal will have catastrophic impacts, including thousands of preventable deaths each year.

Activists warn the new India-UK free trade agreement endangers access to medicines by undermining existing protections.

Mexico launches a national plan to expand domestic drug production and move toward a free, universal, and public healthcare system.

Big Pharma thrives on profiting from publicly funded innovation: but Public Pharma can take back control and put health over profit.

European hospitals and research centers have a chance to make CAR-T cancer therapies more accessible — the question is whether they’ll take it

The EU is mobilizing up to €850 billion for so-called defense and armament, missing out on building true security through investment into health

Big Pharma keeps pushing for weaker pollution standards despite proven risks to human and environmental health

Despite drug shortages and soaring prices, mainstream academia continues to ignore Public Pharma as a solution

The WHO Executive Board will discuss global health priorities this week, including substandard and falsified medical products, with key implications for public pharmaceutical initiatives

Indonesia’s new patent law has raised alarm over potential barriers to accessing life-saving medicines

Protesters condemn Gilead for prioritizing exorbitant profits over public health, accusing the pharmaceutical company of obstructing widespread generic production of new HIV drug lenacapavir